Takeda Pharmaceutical Company Limited announced Masato Iwasaki, Representative Director, Japan General Affairs expressed his intention to retire on June 28th.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,133 JPY | -0.77% | +0.76% | +1.95% |
May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.95% | 41.87B | |
+37.88% | 705B | |
+32.82% | 583B | |
-3.54% | 364B | |
+20.47% | 332B | |
+5.38% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.53% | 169B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Company Limited Announces Masato Iwasaki, Representative Director Expresses His Intention to Retire on June 28Th